| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9236361 | Best Practice & Research Clinical Gastroenterology | 2005 | 9 Pages |
Abstract
It might be relevant to have a low threshold for intestinal biopsies. However, screening asymptomatics may be harmful for individuals. Research is needed to assess the benefits of mass-screening in the future. HLA analysis can contribute towards recognising populations at increased risk.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
C.J.J. (Gastroenterologist), C. (Gastroenterologist),